U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 16:59:54 GMT 2025
Edited
by admin
on Tue Apr 01 16:59:54 GMT 2025
Protein Type MONOCLONAL ANTIBODY AND PEPTIDE FUSION PROTEIN
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
3K7FU8FR2J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IMM-2510
Preferred Name English
Palverafusp Alfa
INN  
Official Name English
human vascular endothelial growth factor receptor 1 (VEGFR-1) fragment 129-228 comprising the second extracellular domain of the VEGF receptor (VEGFR-D2), [N<sup>196</sup>>A<sup>68</sup>]-variant, anti-(human vascular endothelial growth factor (VEGF) (1-
Common Name English
human vascular endothelial growth factor receptor 1 (VEGFR-1) fragment, anti-(human vascular endothelial growth factor (VEGF), fused via a (G4S)3 peptide linker to the N-terminus of both heavy chains of a humanized immunoglobulin G1-kappa anti-(human pro
Common Name English
palverafusp alfa [INN]
Common Name English
103-202-Human vascular endothelial growth factor receptor 1 fusion protein with peptide linker ((GGGGS)3) fusion protein with immunoglobulin G1 [414-alanine,449-alanine,450-alanine] anti-(human programmed death-ligand 1) (human-Mus musculus monoclonal IM
Common Name English
IMM2510
Code English
Code System Code Type Description
SMS_ID
300000054760
Created by admin on Tue Apr 01 16:59:54 GMT 2025 , Edited by admin on Tue Apr 01 16:59:54 GMT 2025
PRIMARY
FDA UNII
3K7FU8FR2J
Created by admin on Tue Apr 01 16:59:54 GMT 2025 , Edited by admin on Tue Apr 01 16:59:54 GMT 2025
PRIMARY
NCI_THESAURUS
C206964
Created by admin on Tue Apr 01 16:59:54 GMT 2025 , Edited by admin on Tue Apr 01 16:59:54 GMT 2025
PRIMARY
INN
12967
Created by admin on Tue Apr 01 16:59:54 GMT 2025 , Edited by admin on Tue Apr 01 16:59:54 GMT 2025
PRIMARY
CAS
2850355-87-0
Created by admin on Tue Apr 01 16:59:54 GMT 2025 , Edited by admin on Tue Apr 01 16:59:54 GMT 2025
PRIMARY
From To
4_134 4_194
4_23 4_88
3_134 3_194
3_23 3_88
1_345 2_345
1_342 2_342
2_336 4_214
1_336 3_214
1_483 1_541
2_483 2_541
1_377 1_437
2_377 2_437
1_260 1_316
2_260 2_316
1_137 1_211
2_137 2_211
1_30 1_79
2_30 2_79
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_36
N 1_413
N 2_36
N 2_413
Related Record Type Details
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_563] [2_563] C-TERMINUS K Amount: LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL